November 7, 2026
Business

HRV Pharma bets ₹150 crore on peptides, high-potency oncology APIs(Soban News)

The investments mark a shift in HRV’s seven-year-old business model—from using available manufacturing capacity to underwriting specialised capacity for products it owns and commercializes

​The investments mark a shift in HRV’s seven-year-old business model—from using available manufacturing capacity to underwriting specialised capacity for products it owns and commercializes by Soban News (international And National News)

Related posts

Wholesale inflation narrows to –0.32% in November as deflationary pressures ease – Moneycontrol(Soban News)

News-Soban-Admin

Anand Mahindra reveals his daily regime that keeps him fit at 70; ‘I’m no fitness guru but I rotate my routine…..” – Times of India(Soban News)

News-Soban-Admin

Indian rupee hits record low: What it means for commodity prices and the economy(Soban News)

News-Soban-Admin

Leave a Comment